HEALTH OF WOMAN. 2016.3(109):24–28 
 

Modern approaches to preinduction and induction of labor, based on the evidence 
 

Vdovychenko Y. P., Zhilka N. Ya., Zhuk S. I., Pryadko N. G.

National Medical Academy of Postgraduate Education P. L. Shupyk, Kiev 
 

Changing approaches to induction of labor prior mandatory cervical preparation with innovative technology is a new step to overcoming aggression in domestic obstetrics and prevention of complications of childbirth. 
 

Key words: induction of labor, peredinduktsiya delivery methods preinduction, prevention, obstetric aggression. 
 

REFERENCES

1. WHO recommendations for induction of labour. WHO. 2011.

2. NICE clinical guideline 70. Induction of labour. Electronic resource. London: National Institute for Health and Clinical Excellence. 2008, July. Access mode: http://www.nhs.uk/planners/pregnancycareplanner/documents/nice_induction_of_labour.pdf. Title from screen.

3. Hofmeyr GJ, Gьlmezoglu AM. 2003. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews. Issue 1. Art. No.: CD000941; DOI: 10. 1002/ 14651858. CD000941

4. Muzonzini G, Hofmeyr GJ. 2004. Buccal or sublingual misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews. Issue 4. Art. No.: CD004221; http://dx.doi.org/10.1002/14651858.CD004221.pub2.

5. Alfirevic Z, Weeks A. 2006. Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews. Issue 2. Art. No.: CD001338. http://dx.doi.org/10.1002/14651858.CD001338.pub2.

6. Novikova VA. Sovremennyie vozmozhnosti preinduktsii prezhdevremennyih rodov v sroke beremennosti 34–36 nedel pri prezhdevremennom razryive plodnyih obolochek Elektronnyiy resurs. Rezhim dostupa: http: http:// www. lvrach. ru/2014/04/15435945. Nazvanie s ekrana.

7. Shalina RI, Zvereva AV, Breusenko LE i dr. 2012. Sravnitelnaya otsenka metodov podgotovki sheyki matki k rodam. Rossiyskiy vestnik akushera-ginekologa 4:49–54.

8. Carroll S, Knowles S. 2013. Clinical practice guideline: preterm prelabour rupture of the membranes. Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Care, Health Service Executive. Guideline 24;Version 1.0:19.

9. Tavassoli F, Ghasemi M, Mohamadzade A, Sharifian J. 2010. Survey of Pregnancy Outcome in Preterm Premature Rupture of Membranes with Amniotic Fluid Index <5 and ≥5. OMJ. 25:118–123. http://dx.doi.org/10.5001/omj.2010.32; PMid:22125713 PMCid:PMC3215489

10. Baev OR i dr. 2012. Podgotovka sheyki matki k rodam i rodovozbuzhdenie: klinicheskiy protokol. M:18.

11. Baev OR i dr. 2013. Medikamentoznaya podgotovka sheyki matki k rodam i rodovozbuzhdenie: klinicheskiy protokol. M, Planida:24.

12. Baev OR, Rumyantseva VP. 2011. Mifepriston v preinduktsii i induktsii rodov. Farmateka 13:75–79.

13. Krasnopolskiy VI, Radzinskiy VE, Bashmakova i dr. 2010. Podgotovka sheyki matki k programmirovannyim rodam. Meditsinskaya tehnologiya. M, Mediabyuro Status Praesens:16.

14. Abramchenko VV. 1997. Sovremennyie predstavleniya o primenenii mifepristona v akusherskoy praktike. Rossiyskiy vestnik akusherstva i ginekologii 2:15–17.

15. Friedman EA. 1977. Labor: clinical evaluation and management. 6-ed. New-York:450.

16. Sidorova IS, Gabrielyan AR. 2004. Effektivnost razlichnyih metodov podgotovki sheyki matki k rodam pri perenashivanii beremennosti. Rossiyskiy vestnik akushera-ginekologa 6:35–38.

17. Hapangama D, Neilson JP. 2009. Mifepristone for induction of labour. Cochrane Database Syst Rev. 3. CD002865. http://dx.doi.org/10.1002/14651858.cd002865.pub2

18. Stenlund PM. 1999. Induction of labor with mifepristone – a randomized, double-blind study versus placebo. Acta Obstet. Gynecol. Scand. 78;9:793–798. http://dx.doi.org/10.1034/j.1600-0412.1999.780910.x; http://dx.doi.org/10.1080/j.1600-0412.1999.780910.x

19. Progestational hormone antagonis ts in complex phase during labor induction. Eur. J. Obstet. Gyneco. Reprod. Biol. 2007. 132;2:163–166. PMid:17010501

20. Fassett MJ, Wing DA. 2008. Uterine activity after oral mifepristone administration in human pregnancies beyond 41 weeks’ gestation. Gynecol. Obstet. Invest. 65;2:112–115. http://dx.doi.org/10.1159/000109167; PMid:17912003

21. Chwalisz K. 1994. The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery. Hum. Reprod. 9:34–39. http://dx.doi.org/10.1093/humrep/9.suppl_1.131

22. Dare MR, Middleton P, Crowther CA et al. 2007. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database Syst. Rev. 4. CD005302. doi: 10. 1002/ 14651858. CD005302. pub2.

23. Flenady V, King J. 2002. Antibiotics for prelabour rupture of membranes at or near term. Cochrane Database Syst. Rev. 3. CD001807. http://dx.doi.org/10.1002/14651858.cd001807

24. Xiao BL, von Hertzen H. 2002. A randomized doubl-blind comparison of two single doses of mifepristone for emergency contraception. Hum Reprod 17(2):3084–9. http://dx.doi.org/10.1093/humrep/17.12.3084; PMid:12456607

25. Zhang W, Wang L. 1999. Mifepristone in treating ectopic pregnancy. Chin Med J 112(4):376–8.